To explore the tumorigenesis mechanism of miR-205 in human gastric cancer and their clinical significance

碩士 === 長庚大學 === 生物醫學研究所 === 100 === Gastric cancer (GC) is the second leading cause of cancer-related death in the worldwide and the sixth in Taiwan . The tumorigenesis of GC is still unknown, and we are still search for the new biomarker to increase patients survival rate. Recent research indicate...

Full description

Bibliographic Details
Main Authors: Yi Da Lu, 盧奕達
Other Authors: K. H. Lin
Format: Others
Published: 2012
Online Access:http://ndltd.ncl.edu.tw/handle/23873285033610484412
id ndltd-TW-100CGU05114056
record_format oai_dc
spelling ndltd-TW-100CGU051140562015-10-13T21:28:02Z http://ndltd.ncl.edu.tw/handle/23873285033610484412 To explore the tumorigenesis mechanism of miR-205 in human gastric cancer and their clinical significance 探討miR-205在胃癌中的致癌機制及其臨床意義 Yi Da Lu 盧奕達 碩士 長庚大學 生物醫學研究所 100 Gastric cancer (GC) is the second leading cause of cancer-related death in the worldwide and the sixth in Taiwan . The tumorigenesis of GC is still unknown, and we are still search for the new biomarker to increase patients survival rate. Recent research indicate that microRNAs could negative regulate the target gene by binding to the 3’UTR of the target gene and inhibit the transcription or translation. microRNAs play important role in not only development and differentiation but tumorigenesis. Preview qRT-PCR profiling of 270 cancer related miRNAs in 6 pair gastric cancer clinical samples indicated that miR-205 was 2.41 time up-regulated in tumor with statistical significance(3-way-ANOVA , Ct<35, p<0.05, 1.5 fold change). In this study, miR-205 was selected as the candidate gene, which were up-regulated in 76.9% of clinical specimens in 52 pair samples, and statistical significantly with the TNM stage. We assumed that miR-205 may played as an onco-miR and correlated with tumor progression in GC. To investigate the biological function of miR-205, we used the lentiviral expression system to establish stable cell lines that were in vitro over-expressed or knocked down of miR-205. And the result indicated that miR-205 would promote cell migration in GC. To search for the potential target gene of miR-205, we correlated our preview iTRAQ database with online database (miRBase) and found Glutathione-s-transferase mu 1 (GSTM1). We validated that GSTM1 could negative regulated by miR-205 using 3’UTR luciferase reporter assay and western blot. In addition, in order to investigate whether GSTM1 could regulate cell migration in GC, we used shRNA to establish GSTM1 knocked down stable cell line and found out that GSTM1 could inhibit cell migration. The data suggest that GSTM1 played as a tumor suppressor. These results indicated that GSTM1 was one of the target gene that regulated by miR-205 to regulate the tumorigenesis of GC. K. H. Lin 林光輝 2012 學位論文 ; thesis 63
collection NDLTD
format Others
sources NDLTD
description 碩士 === 長庚大學 === 生物醫學研究所 === 100 === Gastric cancer (GC) is the second leading cause of cancer-related death in the worldwide and the sixth in Taiwan . The tumorigenesis of GC is still unknown, and we are still search for the new biomarker to increase patients survival rate. Recent research indicate that microRNAs could negative regulate the target gene by binding to the 3’UTR of the target gene and inhibit the transcription or translation. microRNAs play important role in not only development and differentiation but tumorigenesis. Preview qRT-PCR profiling of 270 cancer related miRNAs in 6 pair gastric cancer clinical samples indicated that miR-205 was 2.41 time up-regulated in tumor with statistical significance(3-way-ANOVA , Ct<35, p<0.05, 1.5 fold change). In this study, miR-205 was selected as the candidate gene, which were up-regulated in 76.9% of clinical specimens in 52 pair samples, and statistical significantly with the TNM stage. We assumed that miR-205 may played as an onco-miR and correlated with tumor progression in GC. To investigate the biological function of miR-205, we used the lentiviral expression system to establish stable cell lines that were in vitro over-expressed or knocked down of miR-205. And the result indicated that miR-205 would promote cell migration in GC. To search for the potential target gene of miR-205, we correlated our preview iTRAQ database with online database (miRBase) and found Glutathione-s-transferase mu 1 (GSTM1). We validated that GSTM1 could negative regulated by miR-205 using 3’UTR luciferase reporter assay and western blot. In addition, in order to investigate whether GSTM1 could regulate cell migration in GC, we used shRNA to establish GSTM1 knocked down stable cell line and found out that GSTM1 could inhibit cell migration. The data suggest that GSTM1 played as a tumor suppressor. These results indicated that GSTM1 was one of the target gene that regulated by miR-205 to regulate the tumorigenesis of GC.
author2 K. H. Lin
author_facet K. H. Lin
Yi Da Lu
盧奕達
author Yi Da Lu
盧奕達
spellingShingle Yi Da Lu
盧奕達
To explore the tumorigenesis mechanism of miR-205 in human gastric cancer and their clinical significance
author_sort Yi Da Lu
title To explore the tumorigenesis mechanism of miR-205 in human gastric cancer and their clinical significance
title_short To explore the tumorigenesis mechanism of miR-205 in human gastric cancer and their clinical significance
title_full To explore the tumorigenesis mechanism of miR-205 in human gastric cancer and their clinical significance
title_fullStr To explore the tumorigenesis mechanism of miR-205 in human gastric cancer and their clinical significance
title_full_unstemmed To explore the tumorigenesis mechanism of miR-205 in human gastric cancer and their clinical significance
title_sort to explore the tumorigenesis mechanism of mir-205 in human gastric cancer and their clinical significance
publishDate 2012
url http://ndltd.ncl.edu.tw/handle/23873285033610484412
work_keys_str_mv AT yidalu toexplorethetumorigenesismechanismofmir205inhumangastriccancerandtheirclinicalsignificance
AT lúyìdá toexplorethetumorigenesismechanismofmir205inhumangastriccancerandtheirclinicalsignificance
AT yidalu tàntǎomir205zàiwèiáizhōngdezhìáijīzhìjíqílínchuángyìyì
AT lúyìdá tàntǎomir205zàiwèiáizhōngdezhìáijīzhìjíqílínchuángyìyì
_version_ 1718064509858349056